128 related articles for article (PubMed ID: 4035555)
21. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
22. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting the outcome of surgical treatment of acromegaly.
Er LK; Chang TC; Lin SM; Huang KM; Chang CC
J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950
[TBL] [Abstract][Full Text] [Related]
26. Decrease in human growth hormone (HGH) levels during transsphenoidal surgery for acromegaly as a guide for prognosis.
Yamada S; Shishiba Y; Kitano M; Seki Y; Umezu H; Umezu Y; Ohtsuki N; Yamazaki Y; Aiba T
Endocrinol Jpn; 1985 Dec; 32(6):899-906. PubMed ID: 3833531
[TBL] [Abstract][Full Text] [Related]
27. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
[TBL] [Abstract][Full Text] [Related]
28. [Surgical results and clinical analysis of 19 cases of acromegaly].
Sugimoto S; Abe H; Kaneko S; Tokuda K; Aida T; Tsuru M; Nakagawa K; Akikawa K; Matsubara M
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):241-51. PubMed ID: 3997057
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
30. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
31. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients.
Brockmeier SJ; Buchfelder M; Fahlbusch R
Horm Metab Res; 1993 May; 25(5):275-7. PubMed ID: 8330864
[TBL] [Abstract][Full Text] [Related]
32. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
[TBL] [Abstract][Full Text] [Related]
33. Clinical and endocrinological evaluation of 16 acromegalic patients treated by transsphenoidal surgery.
Leavens ME; Samaan NA; Jesse RH; Byers RM
J Neurosurg; 1977 Dec; 47(6):853-60. PubMed ID: 411899
[TBL] [Abstract][Full Text] [Related]
34. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
Arosio M; Ambrosi B; Guglielmino L; Faglia G
J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
[TBL] [Abstract][Full Text] [Related]
35. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
Beck-Peccoz P; Bassetti M; Spada A; Medri G; Arosio M; Giannattasio G; Faglia G
J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443
[TBL] [Abstract][Full Text] [Related]
37. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
38. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
[TBL] [Abstract][Full Text] [Related]
40. Early postoperative indicators of late outcome in acromegalic patients.
Takahashi JA; Shimatsu A; Nakao K; Hashimoto N
Clin Endocrinol (Oxf); 2004 Mar; 60(3):366-74. PubMed ID: 15009003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
